4//SEC Filing
Ollier Michele 4
Accession 0001181431-10-052250
CIK 0001338042other
Filed
Oct 26, 8:00 PM ET
Accepted
Oct 27, 5:42 PM ET
Size
24.0 KB
Accession
0001181431-10-052250
Insider Transaction Report
Form 4
Ollier Michele
Director10% Owner
Transactions
- Conversion
Series B Convertible Preferred Stock
2010-10-27−782,801→ 0 total(indirect: See Footnotes)Exercise: $0.00→ Common Stock (477,723 underlying) - Conversion
Common Stock
2010-10-27+1,367,346→ 1,371,518 total(indirect: See Footnotes) - Conversion
Common Stock
2010-10-27$7.60/sh+881,128$6,696,573→ 2,730,369 total(indirect: See Footnotes) - Conversion
Series A Convertible Preferred Stock
2010-10-27−3,533,095→ 0 total(indirect: See Footnotes)Exercise: $0.00→ Common Stock (1,367,346 underlying) - Award
Senior Subordinated Convertible Promissory Notes
2010-10-21(indirect: See Footnotes)Exercise: $7.60Exp: 2011-12-31→ Common Stock (881,128 underlying) - Conversion
Senior Subordinated Convertible Promissory Notes
2010-10-27(indirect: See Footnotes)Exercise: $7.60Exp: 2011-12-31→ Common Stock (881,128 underlying) - Conversion
Common Stock
2010-10-27+477,723→ 1,849,241 total(indirect: See Footnotes) - Purchase
Common Stock
2010-10-27$9.50/sh+315,789$2,999,996→ 3,046,158 total(indirect: See Footnotes)
Holdings
- 4,172(indirect: See Footnotes)
Common Stock
Footnotes (9)
- [F1]Michele Ollier, Director of the Issuer, is a partner of Index Ventures which is affiliated with Index Ventures III (Jersey), L.P. ("IVIII Jersey"), Index Ventures III (Delaware), L.P. ("IVIII Delaware"), Index Ventures Parallel Entrepreneur Fund (Jersey) ("IVPEF") and Yucca Partners L.P. (Jersey Branch) as Administrator of the Index Co-Investment Scheme ("Yucca"). Dr. Ollier disclaims beneficial ownership of all such shares held by the foregoing funds, except to the extent of her proportionate pecuniary interest therein.
- [F2]IVIII Jersey is the direct beneficial owner of 1,356 shares of common stock of the Issuer; IVIII Delaware is the direct beneficial owner of 2,754 shares of common stock of the Issuer; IVPEF is the direct beneficial owner of 48 shares of common stock of the Issuer; and Yucca is the direct beneficial owner of 14 shares of common stock of the Issuer.
- [F3]Upon the closing of the Issuer's initial public offering on October 27, 2010, each share of Series A Convertible Preferred Stock (the "Series A Shares") and each share of Series B Convertible Preferred Stock (the "Series B Shares"), plus accrued dividends, immediately converted into shares of common stock of the Issuer in accordance with the terms of the Issuer's Third Amended and Restated Certificate of Incorporation. The Series A Shares converted on a 1-for-0.38701117412 basis and the Series B Shares converted on a 1-for-0.6102765793 basis. The Series A Shares and the Series B Shares were convertible at any time, at the holder's election, and automatically upon the consummation of the Issuer's initial public offering and had no expiration date.
- [F4]IVIII Jersey is the direct beneficial owner of 444,181 shares of common stock issued upon the conversion of its Series A Shares and 153,242 shares of common stock issued upon the conversion of its Series B Shares; IVIII Delaware is the direct beneficial owner of 902,307 shares of common stock issued upon the conversion of its Series A Shares and 311,294 shares of common stock issued upon the conversion of its Series B Shares; IVPEF is the direct beneficial owner of 16,073 shares of common stock issued upon the conversion of its Series A Shares and 5,544 shares of common stock issued upon the conversion of its Series B Shares; and Yucca is the direct beneficial owner of 4,785 shares of common stock issued upon the conversion of its Series A Shares and 7,643 shares of common stock issued upon the conversion of its Series B Shares.
- [F5]The outstanding principal and accrued and unpaid interest on these senior subordinated convertible promissory notes (the "Convertible Notes")automatically converted into shares of common stock upon the closing of the Issuer's initial public offering, at $7.60 per share, 80% of the Issuer's initial public offering price per share.
- [F6]IVIII Jersey is the direct beneficial owner of 285,307 shares of common stock issued upon the conversion of its Convertible Notes; IVIII Delaware is the direct beneficial owner of 579,571 shares of common stock issued upon the conversion of its Convertible Notes; IVPEF is the direct beneficial owner of 10,320 shares of common stock issued upon the conversion of its Convertible Notes; and Yucca is the direct beneficial owner of 5,930 shares of common stock issued upon the conversion of its Convertible Notes.
- [F7]Shares acquired upon the closing of the Issuer's initial public offering at the initial public offering price of $9.50 per share.
- [F8]IVIII Jersey acquired Convertible Notes with a face amouont, including principal and accrued interest, of $2,168,344.80; IVIII Delaware acquired Convertible Notes with a face amount, including principal and accrued interest, of $4,404,755.93; IVPEF acquired Convertible Notes with a face amount, including principal and accrued interest, of $78,461.47; and Yucca acquired Convertible Notes with a face amount, including principal and accrued interest, of $45,110.17.
- [F9]IVIII Delaware is the direct beneficial owner of 315,789 shares of common stock of the Issuer.
Documents
Issuer
Aegerion Pharmaceuticals, Inc.
CIK 0001338042
Entity typeother
Related Parties
1- filerCIK 0001503685
Filing Metadata
- Form type
- 4
- Filed
- Oct 26, 8:00 PM ET
- Accepted
- Oct 27, 5:42 PM ET
- Size
- 24.0 KB